Osteoprotegerin in diabetic osteopathy.

Area of Science:

• Gerontology
• Endocrinology
• Bone Metabolism

Background:

• Type 2 Diabetes Mellitus (T2DM) is associated with bone metabolism alterations.
• Osteoprotegerin (OPG) plays a role in bone remodeling.
• Glycemic control is a critical factor in T2DM management.

Purpose of the Study:

• To investigate the relationship between OPG levels and glycemic control (HbA1c) in elderly subjects.
• To compare OPG levels in diabetic versus non-diabetic elderly individuals.
• To explore the association of OPG with bone mineral density (BMD) and carotid intima-media thickness (IMT).

Main Methods:

• Recruited 172 elderly subjects (107 hip fracture, 65 outpatients).
• Performed geriatric evaluations, blood sampling (HbA1c, OPG, CTX, OC), and DXA scans.
• Measured carotid IMT in outpatients.

Main Results:

• Diabetic patients exhibited higher OPG and BMD, but lower OC and CTX levels.
• OPG was directly correlated with HbA1c, especially in non-fractured subjects.
• Elevated OPG was observed in diabetic patients with high IMT.

Conclusions:

• Elevated OPG and reduced bone turnover markers (OC, CTX) suggest impaired bone quality in diabetic elderly.
• A direct correlation between OPG and HbA1c highlights the impact of glycemic control on bone health.
• Diabetic osteopathy may be a complication of T2DM, linked to glucose control and disease duration.